Calico Life Sciences announced on Thursday that the U.S. Food and Drug Administration (FDA) has issued Fast Track Designation ...
Squibb announced that the FDA has granted Fast Track Designation to BMS-986446, a potential best-in-class anti-microtubule ...
The FDA has granted fast track designation to UB-VV111 for the treatment of relapsed/refractory large B-cell lymphoma (LBCL) following 2 or more prior lines of therapy and relapsed/refractory chronic ...
Bristol Myers Squibb has won Food and Drug Administration fast-track designation for its BMS-986446 drug candidate in Alzheimer's disease. Bristol Myers on Wednesday said BMS-986446 is a potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results